L1CAM and neoplasm: A limitation of our study was that this was a relatively small cohort of EC patients with a shorter follow-up period and therefore a low recurrence rate, as it was a pilot study aimed at finding a reasonable preliminary evidence for future research on DJ1 and L1CAM as serum circulation tumor biomarkers in EC patients.